Mavacamten Alternatives Compared
| Mavacamten | Camzyos (mavacamten) | Nifedipine |
|
|---|
| Mavacamten | Camzyos (mavacamten) | Nifedipine |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hypertrophic Cardiomyopathy. Mavacamten may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hypertrophic Cardiomyopathy. Camzyos may also be used for purposes not listed in this medication guide. |
Prescription only
Nifedipine is used in the treatment of vasospastic angina and occasionally for chronic unstable angina as an add-on to other treatments. It should not be used to rapidly drop blood pressure as this... View more |
||||||||
| More about Mavacamten | More about Camzyos (mavacamten) | More about Nifedipine | ||||||||
| Ratings & Reviews | ||||||||||
|
Mavacamten has an average rating of 8.4 out of 10 from a total of 13 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
Camzyos has an average rating of 8.6 out of 10 from a total of 9 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 0% reported a negative effect. |
Nifedipine has an average rating of 5.0 out of 10 from a total of 164 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 43% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Mavacamten side effects |
View all Camzyos side effects |
View all Nifedipine side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
Lower cost generic |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Camzyos prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
| Camzyos |
N/A |
Afeditab CR, Procardia, Procardia XL | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
216 hours |
216 hours |
5 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 487 drugs are known to interact with Mavacamten:
|
A total of 487 drugs are known to interact with Camzyos:
|
A total of 631 drugs are known to interact with Nifedipine:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
|||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
April 28, 2022 |
April 28, 2022 |
December 31, 1981 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.